These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27600870)

  • 1. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli.
    Stanasila L; Lim WK; Neubig RR; Pattus F
    J Neurochem; 2000 Sep; 75(3):1190-9. PubMed ID: 10936202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of G-proteins by mu-opioid receptor agonists.
    Saidak Z; Blake-Palmer K; Hay DL; Northup JK; Glass M
    Br J Pharmacol; 2006 Mar; 147(6):671-80. PubMed ID: 16415903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
    J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I.
    Burford NT; Tolbert LM; Sadee W
    Eur J Pharmacol; 1998 Jan; 342(1):123-6. PubMed ID: 9544801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
    Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
    Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation.
    Clark MJ; Furman CA; Gilson TD; Traynor JR
    J Pharmacol Exp Ther; 2006 May; 317(2):858-64. PubMed ID: 16436499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
    Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
    Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
    Xie H; Woods JH; Traynor JR; Ko MC
    Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.
    Mizoguchi H; Wu HE; Narita M; Sora I; Hall SF; Uhl GR; Loh HH; Nagase H; Tseng LF
    J Pharmacol Sci; 2003 Dec; 93(4):423-9. PubMed ID: 14737012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
    Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
    J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
    Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
    J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.
    Sim LJ; Liu Q; Childers SR; Selley DE
    J Neurochem; 1998 Apr; 70(4):1567-76. PubMed ID: 9523574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
    Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
    Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
    Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
    Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
    Chaipatikul V; Loh HH; Law PY
    J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.